{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "News Analysis; arrest of Turing Pharmaceuticals chief executive Martin Shkreli on securities fraud charges in some ways has taken heat off of other drug firms; most of them will redouble efforts to distance themselves from greedy executive, who is blamed for sparking outrage over drug prices.", "type_of_material": "An Analysis; News Analysis", "word_count": "1341", "lead_paragraph": "Pharmaceutical executives can look at the federal indictment and say that Martin Shkreli is an aberration, a rotten apple, but his arrest is not likely to make concern about drug prices go away.", "pub_date": "2015-12-18T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Martin Shkreli\u2019s Arrest Gives Drug Makers Cover", "content_kicker": "News Analysis", "print_headline": "An Executive&#8217;s Arrest Gives Drug Makers Cover", "kicker": "News Analysis"}, "snippet": "Pharmaceutical executives can look at the federal indictment and say that Martin Shkreli is an aberration, a rotten apple, but his arrest is not likely to make concern about drug prices go away.", "multimedia": [{"height": 126, "url": "images/2015/10/13/business/13drug-web1/13drug-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/10/13/business/13drug-web1/13drug-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/10/13/business/13drug-web1/13drug-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/10/13/business/13drug-web1/13drug-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/10/13/business/13drug-web1/13drug-web1-thumbStandard-v4.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/10/13/business/13drug-web1/13drug-web1-thumbStandard-v4.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/12/18/business/martin-shkreli-arrest-gives-drug-makers-cover.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Shkreli, Martin (1983- )", "name": "persons"}, {"rank": "2", "is_major": "Y", "value": "Securities and Commodities Violations", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Turing Pharmaceuticals AG", "name": "organizations"}, {"rank": "4", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Hedge Funds", "name": "subject"}], "blog": [], "_id": "5673681738f0d85bed90f484", "source": "The New York Times"}